Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
Pages
▼
Saturday, March 29, 2014
FDA Advisors Question Safety and Effectiveness of Diabetes Device, Afrezza
An initial review by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee of the experimental inhaled insulin device Afrezza has raised questions about the product's safety and effectiveness.
No comments:
Post a Comment